Gujarat Themis Biosyn: CFO Bhavik Shah steps down, Krupesh Patel named new CFO

Cfo ResignedKmp ResignedManagement Changes View source PDF Explain this filing

GUJTHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.9%Reaction day

₹327.00

prior close

₹325.10

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.8%-0.1% vs market

Pharmaceuticals peers, median of 159sector-0.6%-0.3% vs sector

On the reaction day the stock moved 0.1 pts less than Nifty Microcap 250 and 0.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.0

10m

-1.5

15m

-1.1

30m

-1.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.9-0.8-0.1-0.6-0.3

Next day

+1.9+1.8+0.1+1.1+0.7

+3.2+2.8+0.4+1.7+1.6

+0.9+2.3-1.3+1.3-0.4

-3.2+1.8-5.0+0.7-3.9

-2.7+0.3-3.0+0.0-2.7

-2.0+0.5-2.6-0.2-1.9

15d

-6.7-2.5-4.2-2.3-4.4

-9.4-6.3-3.1-4.4-5.1

-20.3-8.0-12.3-7.2-13.1

+15.6+8.3+7.3+2.6+13.0

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 159Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Gujarat Themis Biosyn's board approved Q3 FY26 results: revenue INR 4,336.82 lakhs (up from 3,951.98 a year ago), net profit INR 1,246.46 lakhs (slightly lower than 1,297.23 YoY). CFO Bhavik Shah steps down from April 1, 2026 to take a new internal role as Senior Accounts Manager. Krupesh Patel, with 15 years experience across pharma, steel and defence sectors including Tata Advanced Systems and Blue Star, appointed as new CFO and KMP. Independent director Kirandeep Madan reappointed for a second 5-year term from May 1, 2026.

Likely market impact

CFO transition appears orderly and internal. Q3 net profit dipped marginally YoY despite revenue growth. No major red flags for shareholders.